Radio frequency identification technology reduce intravenous thrombolysis time in acute ischemic stroke.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 31 03 2023
accepted: 21 06 2023
medline: 21 7 2023
pubmed: 19 7 2023
entrez: 19 7 2023
Statut: epublish

Résumé

To inspect whether time management with radio frequency identification technology (RFID) reduces symptom onset-to-intravenous thrombolysis time (OTT) in acute ischemic stroke (AIS). In the retrospective study, patients with AIS, transferred by Emergency Medical Services (EMS) to Hunan Provincial People's Hospital between September 2019 to June 2022, divided into three groups, as traditional group, in-hospital RFID group and whole process RFID group. Baseline characteristics and time metrics were compared. After the whole emergency process applied with RFID time management, Door to intravenous thrombolysis time (DNT) was reduced from 125.00±43.16 min to 32.59±25.45 min (F = 121.857, p<0.001), and OTT was reduced from 235.53±57.27 min to 144.31±47.96 min (F = 10.377, p<0.001). Time management with RFID is effective in reducing OTT in AIS patients with thrombolysis treatment.

Identifiants

pubmed: 37467248
doi: 10.1371/journal.pone.0288207
pii: PONE-D-23-08801
pmc: PMC10355394
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0288207

Informations de copyright

Copyright: © 2023 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2021 Mar 25;16(3):e0247829
pubmed: 33765030
PLoS One. 2020 Sep 11;15(9):e0238305
pubmed: 32915811
Eur J Emerg Med. 2022 Feb 01;29(1):56-62
pubmed: 34483249
Front Neurol. 2022 Sep 26;13:931193
pubmed: 36226088
Neurology. 2013 Sep 17;81(12):1071-6
pubmed: 23946303
Stroke. 2013 Sep;44(9):2620-2
pubmed: 23839507
Stroke. 2006 Jan;37(1):263-6
pubmed: 16339467
BMC Emerg Med. 2022 Jul 26;22(1):136
pubmed: 35883030
Front Neurol. 2022 Oct 13;13:1005819
pubmed: 36313493
Front Neurol. 2021 Nov 24;12:741551
pubmed: 34899564
JMIR Med Inform. 2019 Aug 05;7(3):e9510
pubmed: 31381503
Risk Manag Healthc Policy. 2022 Sep 13;15:1741-1749
pubmed: 36124298
PLoS One. 2022 Oct 10;17(10):e0275831
pubmed: 36215281
PLoS One. 2017 Dec 5;12(12):e0188231
pubmed: 29206838
Lancet Neurol. 2017 Mar;16(3):227-237
pubmed: 28229894
PLoS One. 2023 Jan 19;18(1):e0278709
pubmed: 36656912
Front Neurol. 2021 Nov 01;12:728012
pubmed: 34790159
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106179
pubmed: 34735901
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Neurosurgery. 2019 Jul 1;85(suppl_1):S38-S46
pubmed: 31197342

Auteurs

Yixiong Zhang (Y)

The First People's Hospital of Huaihua, Huaihua City, China.

Yingxia Jing (Y)

Poisoning Research Laboratory, Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliate Hospital of Hunan Normal University, Changsha City, China.

Yimin Zhu (Y)

Poisoning Research Laboratory, Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliate Hospital of Hunan Normal University, Changsha City, China.

Tao Jiang (T)

The First People's Hospital of Huaihua, Huaihua City, China.

Xianyi Tang (X)

Poisoning Research Laboratory, Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliate Hospital of Hunan Normal University, Changsha City, China.

Weichen Yi (W)

The First People's Hospital of Huaihua, Huaihua City, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH